search icon

    Market Snapshot

    • S&P Futures

      3,779.5

    • Dow Futures

      30,569

    • Nasdaq Futures

      11,622.75

    blog search icon

    Alterity Therapeutics Limited

    (NASDAQ:ATHE)

    $0.62

    $-0.01

    -0.65%

    Alterity Therapeutics Limited Chart

    ATHE Stock Price Today

    Alterity Therapeutics Limited (ATHE) stock declined over -0.65% intraday to trade at $0.62 a share on NASDAQ. The stock opened with a loss of -1.59% at $0.62 and touched an intraday high of $0.66, rising 1.64% against the last close of $0.61. The stock went to a low of $0.62 during the session.

    Stock Snapshot

    $0.61

    Prev. Close

    21.36 Million

    Market Cap

    $0.62

    Day Low

    $0.62

    Open

    40.09 Million

    Number of Shares

    $0.66

    Day High

    -

    P/E ratio

    -0.25

    EPS (TTM)

    0.92

    Cash Flow per Share

    0.87

    Free Float in %

    0.90

    Book Value

    11,955

    Volume

    Alterity Therapeutics Limited Historical Data

    DateOpenHighLowCloseVolume
    2022-07-01$0.62$0.66$0.62$0.638,200
    2022-06-30$0.63$0.65$0.61$0.6129,600
    2022-06-29$0.63$0.68$0.63$0.6415,200
    2022-06-28$0.63$0.68$0.63$0.6565,800
    2022-06-27$0.6$0.69$0.6$0.65157,400
    2022-06-24$0.64$0.64$0.6$0.63106,100
    2022-06-23$0.61$0.67$0.61$0.64163,000
    2022-06-22$0.62$0.66$0.61$0.6191,800
    2022-06-21$0.6$0.67$0.6$0.616,200
    2022-06-17$0.63$0.64$0.6$0.638,700

    Contact Details

    460 Bourke Street
    Level 3
    Melbourne, VIC 3000
    Australia

    Webiste:ATHE

    61 3 9349 4906

    Company Information

    Employees-

    Beta1.32

    Sales or Revenue4.82 Million

    5Y Sales Change-

    Fiscal Year Ends2021-06-29

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

    Frequently Asked Questions

    icon

    What is the current Alterity Therapeutics Limited (ATHE) stock price?

    Alterity Therapeutics Limited (NASDAQ: ATHE) stock price is $0.62 as of the last check on Friday, July 1. During the trading session, ATHE stock reached the peak price of $0.66 while $0.62 was the lowest point it dropped to.

    icon

    ATHE's industry and sector of operation?

    The NASDAQ listed ATHE is part of Biotechnology industry that operates in the broader Health Care sector. Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease.

    icon

    Who are the executives of ATHE?

    Mr. Geoffrey Paul Kempler B.Sc, B.Sc.
    Co-Founder & Non-Exec. Chairman
    Dr. David A. Stamler M.D.
    Chief Exec. Officer
    Ms. Kathryn J. E. Andrews
    Chief Financial Officer
    Dr. Rudolf Emile Tanzi Ph.D.
    Chief Scientific Advisor and Member of R&D Advisory Board

    icon

    What is the ATHE stock price today?

    ATHE stock traded closed the last session at $0.63, which is $-0.01 or -0.65% lower than its previous close of $0.61. ATHE's current trading price is 7.55% lower than its 52-week high of $2.13 where as its distance from 52-week low of 0.58% is -70.71%.

    icon

    How many employees does ATHE have?

    Number of ATHE employees currently stands at -. ATHE operates from 460 Bourke Street, Level 3, Melbourne, VIC 3000, Australia.

    icon

    Link for ATHE official website?

    Official Webiste of $ATHE is: https://alteritytherapeutics.com

    icon

    How do I contact ATHE?

    ATHE could be contacted at ATHE operates from 460 Bourke Street, Level 3, Melbourne, VIC 3000, Australia, or at phone #61 3 9349 4906 and can also be accessed through its website.

    icon

    How many shares of ATHE are traded daily?

    ATHE stock volume for the day was 11,955 shares while in the previous session number of ATHE shares traded was 8,200 . The average number of ATHE shares traded daily for last 3 months was 84.43 Thousands.

    icon

    How much did ATHE change today?

    The percentage change in ATHE stock occurred in the recent session was -0.65% while the dollar amount for the price change in ATHE stock was $-0.01.

    icon

    What price range ATHE stock been trading in?

    In the recent session, the day high for ATHE stock was $0.66 while the low for ATHE stock touched on the day was $0.62.

    icon

    What is the market cap of ATHE currently?

    The market value of ATHE currently stands at 21.36 Million with its latest stock price at $0.62 and 40.09 Million of its shares outstanding.